Princeton Capital Management’s Merck MRK Stock Holding History

Princeton Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$350K	Buy	2,909 +709	+32%	+$81.9K	0.1%	100
2025 Q4	$232K	Buy	+2,200	New	+$207K	0.06%	134
2025 Q2	–	Sell	-15,192	Closed	-$1.36M	–	133
2025 Q1	$1.36M	Sell	15,192 -1,234	-8%	-$115K	0.48%	39
2024 Q4	$1.63M	Sell	16,426 -8,067	-33%	-$832K	0.51%	32
2024 Q3	$2.78M	Buy	24,493 +62	+0.3%	+$7.37K	0.88%	22
2024 Q2	$3.02M	Sell	24,431 -7	-0%	-$902	0.99%	21
2024 Q1	$3.22M	Buy	24,438 +7,271	+42%	+$896K	1.16%	19
2023 Q4	$1.87M	Sell	17,167 -6,607	-28%	-$686K	0.75%	29
2023 Q3	$2.45M	Buy	23,774 +218	+0.9%	+$23.5K	1.13%	20
2023 Q2	$2.72M	Buy	23,556 +197	+0.8%	+$22.4K	1.13%	23
2023 Q1	$2.49M	Buy	23,359 +15,820	+210%	+$1.71M	1.06%	26
2022 Q4	$836K	Buy	7,539 +1,239	+20%	+$127K	0.37%	51
2022 Q3	$543K	Hold	6,300	–	–	0.24%	63
2022 Q2	$574K	Buy	6,300 +1	+0%	+$89	0.22%	68
2022 Q1	$517K	Buy	6,299 +35	+0.6%	+$2.76K	0.16%	72
2021 Q4	$480K	Hold	6,264	–	–	0.14%	77
2021 Q3	$470K	Buy	6,264 +50	+0.8%	+$3.8K	0.15%	76
2021 Q2	$483K	Sell	6,214 -298	-5%	-$22.2K	0.15%	73
2021 Q1	$479K	Sell	6,512 -218	-3%	-$16.1K	0.16%	72
2020 Q4	$525K	Buy	6,730 +114	+2%	+$8.72K	0.19%	65
2020 Q3	$524K	Sell	6,616 -392	-6%	-$30.7K	0.21%	62
2020 Q2	$517K	Sell	7,008 -1,424	-17%	-$107K	0.23%	59
2020 Q1	$621K	Sell	8,432 -1,531	-15%	-$120K	0.32%	52
2019 Q4	$809K	Hold	9,963	–	–	0.36%	48
2019 Q3	$800K	Hold	9,963	–	–	0.39%	46
2019 Q2	$797K	Hold	9,963	–	–	0.39%	48
2019 Q1	$791K	Hold	9,963	–	–	0.4%	46
2018 Q4	$726K	Hold	9,963	–	–	0.42%	44
2018 Q3	$674K	Sell	9,963 -152	-2%	-$9.68K	0.28%	55
2018 Q2	$586K	Hold	10,115	–	–	0.25%	58
2018 Q1	$526K	Buy	10,115 +393	+4%	+$21.2K	0.23%	59
2017 Q4	$522K	Buy	+9,722	New	+$539K	0.23%	58
2014 Q4	–	Sell	-29,606	Closed	-$1.68M	–	91
2014 Q3	$1.68M	Sell	29,606 -1,592	-5%	-$89.4K	1.52%	25
2014 Q2	$1.72M	Buy	31,198 +143	+0.5%	+$7.8K	1.45%	34
2014 Q1	$1.68M	Sell	31,055 -768	-2%	-$39.8K	1.42%	31
2013 Q4	$1.52M	Buy	31,823 +3,105	+11%	+$142K	1.26%	49
2013 Q3	$1.3M	Sell	28,718 -678	-2%	-$31K	1.19%	54
2013 Q2	$1.3M	Buy	+29,396	New	+$1.31M	1.23%	52

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Princeton Capital Management's MRK Position: Q1 2026 in Review

Princeton Capital Management increased its Merck (MRK) stake by 32% in Q1 2026, buying an estimated $81.9K and bringing the position to 2,909 shares worth $350K. The position accounts for 0.1% of the portfolio, ranked #100.

Princeton Capital Management first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $3.22M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Princeton Capital Management held 2,909 shares of Merck worth $350K as of Q1 2026.
Princeton Capital Management bought 709 Merck shares in Q1 2026, an estimated $81.9K.
Merck made up 0.1% of Princeton Capital Management's portfolio in Q1 2026, its #100 holding.
Princeton Capital Management first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
Princeton Capital Management's Merck position peaked at $3.22M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Princeton Capital Management's 13F filing for Q1 2026, filed 8 May 2026.